N-[N'-[1,1,2,2-tetradeuterio-2-(2,3,4,5-tetradeuteriophenyl)ethyl]carbamimidoyl]ethanimidamide
C11H16N4 — CID 176523415
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[N'-[1,1,2,2-tetradeuterio-2-(2,3,4,5-tetradeuteriophenyl)ethyl]carbamimidoyl]ethanimidamide
N-[N'-[1,1,2,2-tetradeuterio-2-(2,3,4,5-tetradeuteriophenyl)ethyl]carbamimidoyl]ethanimidamide (PubChem CID 176523415) has the molecular formula C11H16N4 and a molecular weight of 212.33 g/mol. Its IUPAC name is N-[N'-[1,1,2,2-tetradeuterio-2-(2,3,4,5-tetradeuteriophenyl)ethyl]carbamimidoyl]ethanimidamide.
Molecular Properties
| Compound Name | N-[N'-[1,1,2,2-tetradeuterio-2-(2,3,4,5-tetradeuteriophenyl)ethyl]carbamimidoyl]ethanimidamide |
|---|---|
| PubChem CID | 176523415 |
| Molecular Formula | C11H16N4 |
| Molecular Weight | 212.33 g/mol |
| Exact Mass | 212.19 |
| IUPAC Name | N-[N'-[1,1,2,2-tetradeuterio-2-(2,3,4,5-tetradeuteriophenyl)ethyl]carbamimidoyl]ethanimidamide |
| SMILES | [H]/N=C(\C)N/C(N)=N/C([2H])([2H])C([2H])([2H])c1cc([2H])c([2H])c([2H])c1[2H] |
| InChI | InChI=1S/C11H16N4/c1-9(12)15-11(13)14-8-7-10-5-3-2-4-6-10/h2-6H,7-8H2,1H3,(H4,12,13,14,15)/i2D,3D,4D,5D,7D2,8D2 |
| InChIKey | RHNOFMBNSFLJPW-APZHOWBQSA-N |
| XLogP | 1.13 |
| TPSA | 74.26 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 2 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 15 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 212.33 |
| LogP ≤ 5 | 1.13 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 2 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'imine_2', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 176523415 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.